Therapeutic potential of targeting the Wnt/β-catenin signaling pathway in colorectal cancer
Tóm tắt
Từ khóa
Tài liệu tham khảo
Bray, 2018, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J. Clin., 10.3322/caac.21492
Cross, 2010, A large prospective study of meat consumption and colorectal cancer risk: an investigation of potential mechanisms underlying this association, Cancer Res., 70, 2406, 10.1158/0008-5472.CAN-09-3929
Brenner, 2012, Progress in colorectal cancer survival in Europe from the late 1980s to the early 21st century: the EUROCARE study, International journal of cancer, Int. J. Cancer Suppl., 131, 1649, 10.1002/ijc.26192
Chang, 2007, Lymph node evaluation and survival after curative resection of colon cancer: systematic review, J. Natl. Cancer Inst., 99, 433, 10.1093/jnci/djk092
Arkenau, 2008, Efficacy of oxaliplatin plus capecitabine or infusional fluorouracil/leucovorin in patients with metastatic colorectal cancer: a pooled analysis of randomized trials, J. Clin. Oncol., 26, 5910, 10.1200/JCO.2008.16.7759
Clevers, 2006, Wnt/beta-catenin signaling in development and disease, Cell, 127, 469, 10.1016/j.cell.2006.10.018
Veeman, 2003, A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling, Dev. Cell, 5, 367, 10.1016/S1534-5807(03)00266-1
Giles, 2003, Caught up in a Wnt storm: wnt signaling in cancer, Biochim. Biophys. Acta, 1653, 1
Kikuchi, 2008, Tumor formation due to abnormalities in the beta-catenin-independent pathway of Wnt signaling, Cancer Sci., 99, 202, 10.1111/j.1349-7006.2007.00675.x
MacDonald, 2009, Wnt/beta-catenin signaling: components, mechanisms, and diseases, Dev. Cell, 17, 9, 10.1016/j.devcel.2009.06.016
Rubinfeld, 1993, Association of the APC gene product with beta-catenin, Science, 262, 1731, 10.1126/science.8259518
Su, 1993, Association of the APC tumor suppressor protein with catenins, Science, 262, 1734, 10.1126/science.8259519
Behrens, 1996, Functional interaction of beta-catenin with the transcription factor LEF-1, Nature, 382, 638, 10.1038/382638a0
Bhanot, 1996, A new member of the frizzled family from Drosophila functions as a Wingless receptor, Nature, 382, 225, 10.1038/382225a0
Vermeulen, 2010, Wnt activity defines colon cancer stem cells and is regulated by the microenvironment, Nat. Cell Biol., 12, 468, 10.1038/ncb2048
Potten, 1988, Epithelial stem cells in vivo, J. Cell Sci. Suppl., 10, 45, 10.1242/jcs.1988.Supplement_10.4
Farin, 2016, Visualization of a short-range Wnt gradient in the intestinal stem-cell niche, Nature, 530, 340, 10.1038/nature16937
van de Wetering, 2002, The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells, Cell, 111, 241, 10.1016/S0092-8674(02)01014-0
Gregorieff, 2005, Expression pattern of Wnt signaling components in the adult intestine, Gastroenterology, 129, 626, 10.1016/j.gastro.2005.06.007
Kuhnert, 2004, Essential requirement for wnt signaling in proliferation of adult small intestine and colon revealed by adenoviral expression of dickkopf-1, Proceedings of the National Academy of Sciences of the United States of America, 101, 266, 10.1073/pnas.2536800100
Korinek, 1998, Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4, Nat. Genet., 19, 379, 10.1038/1270
van Es, 2012, A critical role for the Wnt effector Tcf4 in adult intestinal homeostatic self-renewal, Mol. Cell. Biol., 32, 1918, 10.1128/MCB.06288-11
Kim, 2005, Mitogenic influence of human R-spondin1 on the intestinal epithelium, Science, 309, 1256, 10.1126/science.1112521
Sato, 2009, Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche, Nature, 459, 262, 10.1038/nature07935
Jass, 2007, Classification of colorectal cancer based on correlation of clinical, morphological and molecular features, Histopathology, 50, 113, 10.1111/j.1365-2559.2006.02549.x
N. Cancer Genome Atlas, 2012, Comprehensive molecular characterization of human colon and rectal cancer, Nature, 487, 330, 10.1038/nature11252
Morin, 1997, Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC, Science, 275, 1787, 10.1126/science.275.5307.1787
Suraweera, 2006, Mutations within Wnt pathway genes in sporadic colorectal cancers and cell lines, International journal of cancer, Int. J. Cancer Suppl., 119, 1837, 10.1002/ijc.22046
Kitaeva, 1997, Mutations in beta-catenin are uncommon in colorectal cancer occurring in occasional replication error-positive tumors, Cancer Res., 57, 4478
Markowitz, 2009, Molecular origins of cancer: molecular basis of colorectal cancer, N. Engl. J. Med., 361, 2449, 10.1056/NEJMra0804588
Batra, 2006, Wnt inhibitory factor-1, a Wnt antagonist, is silenced by promoter hypermethylation in malignant pleural mesothelioma, Biochem. Biophys. Res. Commun., 342, 1228, 10.1016/j.bbrc.2006.02.084
Suzuki, 2004, Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer, Nat. Genet., 36, 417, 10.1038/ng1330
Ying, 2008, WNT5A exhibits tumor-suppressive activity through antagonizing the Wnt/beta-catenin signaling, and is frequently methylated in colorectal cancer, Clin. Cancer Res., 14, 55, 10.1158/1078-0432.CCR-07-1644
Polakis, 1999, Defects in the regulation of beta-catenin in colorectal cancer, Adv. Exp. Med. Biol., 470, 23, 10.1007/978-1-4615-4149-3_3
Polakis, 1999, The oncogenic activation of beta-catenin, Curr. Opin. Genet. Dev., 9, 15, 10.1016/S0959-437X(99)80003-3
Baldus, 2004, MUC1 and nuclear beta-catenin are coexpressed at the invasion front of colorectal carcinomas and are both correlated with tumor prognosis, Clin. Cancer Res., 10, 2790, 10.1158/1078-0432.CCR-03-0163
He, 1998, Identification of c-MYC as a target of the APC pathway, Science, 281, 1509, 10.1126/science.281.5382.1509
Tetsu, 1999, Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells, Nature, 398, 422, 10.1038/18884
Brabletz, 1999, Beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer, Am. J. Pathol., 155, 1033, 10.1016/S0002-9440(10)65204-2
Crawford, 1999, The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors, Oncogene, 18, 2883, 10.1038/sj.onc.1202627
Spears, 2011, Novel double-negative feedback loop between adenomatous polyposis coli and Musashi1 in colon epithelia, J. Biol. Chem., 286, 4946, 10.1074/jbc.C110.205922
Yang, 2006, Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines, Clin. Cancer Res., 12, 4147, 10.1158/1078-0432.CCR-06-0038
ten Berge, 2011, Embryonic stem cells require Wnt proteins to prevent differentiation to epiblast stem cells, Nat. Cell Biol., 13, 1070, 10.1038/ncb2314
Kahn, 2011, Symmetric division versus asymmetric division: a tale of two coactivators, Future Med. Chem., 3, 1745, 10.4155/fmc.11.126
Barker, 2010, Leucine-rich repeat-containing G-protein-coupled receptors as markers of adult stem cells, Gastroenterology, 138, 1681, 10.1053/j.gastro.2010.03.002
Wielenga, 1999, Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway, Am. J. Pathol., 154, 515, 10.1016/S0002-9440(10)65297-2
Shulewitz, 2006, Repressor roles for TCF-4 and Sfrp1 in Wnt signaling in breast cancer, Oncogene, 25, 4361, 10.1038/sj.onc.1209470
Katoh, 2007, Comparative genomics on PROM1 gene encoding stem cell marker CD133, Int. J. Mol. Med., 19, 967
Yamada, 2000, Transactivation of the multidrug resistance 1 gene by T-cell factor 4/beta-catenin complex in early colorectal carcinogenesis, Cancer Res., 60, 4761
Munz, 2009, The emerging role of EpCAM in cancer and stem cell signaling, Cancer Res., 69, 5627, 10.1158/0008-5472.CAN-09-0654
Curtin, 2010, Drug discovery approaches to target Wnt signaling in cancer stem cells, Oncotarget, 1, 552, 10.18632/oncotarget.191
Dow, 2015, Apc restoration promotes cellular differentiation and reestablishes crypt homeostasis in colorectal Cancer, Cell, 161, 1539, 10.1016/j.cell.2015.05.033
Nusse, 2017, Wnt/beta-catenin signaling, disease, and emerging therapeutic modalities, Cell, 169, 985, 10.1016/j.cell.2017.05.016
Sherman, 2014, Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy, Cell, 159, 80, 10.1016/j.cell.2014.08.007
Patel, 2008, Curcumin enhances the effects of 5-fluorouracil and oxaliplatin in mediating growth inhibition of colon cancer cells by modulating EGFR and IGF-1R, Int. J. Cancer, 122, 267, 10.1002/ijc.23097
Huang, 2017, Curcumin enhances the effects of irinotecan on colorectal cancer cells through the generation of reactive oxygen species and activation of the endoplasmic reticulum stress pathway, Oncotarget, 8, 40264, 10.18632/oncotarget.16828
Lev-Ari, 2005, Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells, Clin. Cancer Res., 11, 6738, 10.1158/1078-0432.CCR-05-0171
Patel, 2010, Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients, Cancer Res., 70, 7392, 10.1158/0008-5472.CAN-10-2027
Holcombe, 2015, Effects of a grape-supplemented diet on proliferation and Wnt signaling in the colonic mucosa are greatest for those over age 50 and with high arginine consumption, Nutr. J., 14, 62, 10.1186/s12937-015-0050-z
Gray, 2017, Evaluation of PTGS2 expression, PIK3CA mutation, aspirin use and Colon Cancer survival in a population-based cohort study, Clin. Transl. Gastroenterol., 8, e91, 10.1038/ctg.2017.18
Dihlmann, 2001, The nonsteroidal anti-inflammatory drugs aspirin and indomethacin attenuate beta-catenin/TCF-4 signaling, Oncogene, 20, 645, 10.1038/sj.onc.1204123
Chen, 2009, Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer, Nat. Chem. Biol., 5, 100, 10.1038/nchembio.137
Madan, 2016, Wnt addiction of genetically defined cancers reversed by PORCN inhibition, Oncogene, 35, 2197, 10.1038/onc.2015.280
Wickstrom, 2015, Wnt/beta-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance, Nat. Commun., 6, 8904, 10.1038/ncomms9904
Liu, 2016, LMO2 attenuates tumor growth by targeting the Wnt signaling pathway in breast and colorectal cancer, Sci. Rep., 6, 36050, 10.1038/srep36050
Wang, 2015, Targeted inhibition of disheveled PDZ domain via NSC668036 depresses fibrotic process, Exp. Cell Res., 331, 115, 10.1016/j.yexcr.2014.10.023
Fan, 2014, Wnt/beta-catenin signaling induces the transcription of cystathionine-gamma-lyase, a stimulator of tumor in colon cancer, Cell. Signal., 26, 2801, 10.1016/j.cellsig.2014.08.023
Kulak, 2015, Disruption of Wnt/beta-Catenin signaling and telomeric shortening are inextricable consequences of tankyrase inhibition in human cells, Mol. Cell. Biol., 35, 2425, 10.1128/MCB.00392-15
Lau, 2013, A novel tankyrase small-molecule inhibitor suppresses APC mutation-driven colorectal tumor growth, Cancer Res., 73, 3132, 10.1158/0008-5472.CAN-12-4562
Thorne, 2010, Small-molecule inhibition of Wnt signaling through activation of casein kinase 1alpha, Nat. Chem. Biol., 6, 829, 10.1038/nchembio.453
Lepourcelet, 2004, Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex, Cancer Cell, 5, 91, 10.1016/S1535-6108(03)00334-9
Gonsalves, 2011, An RNAi-based chemical genetic screen identifies three small-molecule inhibitors of the Wnt/wingless signaling pathway, Proc. Natl. Acad. Sci. U. S. A., 108, 5954, 10.1073/pnas.1017496108
Shin, 2017, A small molecule inhibitor of the beta-Catenin-TCF4 interaction suppresses colorectal Cancer growth in vitro and in vivo, EBioMedicine, 25, 22, 10.1016/j.ebiom.2017.09.029
Hwang, 2016, Direct targeting of beta-catenin by a small molecule stimulates proteasomal degradation and suppresses oncogenic Wnt/beta-Catenin signaling, Cell Rep., 16, 28, 10.1016/j.celrep.2016.05.071
Leal, 2015, Inhibition of the Tcf/beta-catenin complex increases apoptosis and impairs adrenocortical tumor cell proliferation and adrenal steroidogenesis, Oncotarget, 6, 43016, 10.18632/oncotarget.5513
Fang, 2016, A small-molecule antagonist of the beta-Catenin/TCF4 interaction blocks the self-renewal of Cancer stem cells and suppresses tumorigenesis, Cancer Res., 76, 891, 10.1158/0008-5472.CAN-15-1519
Kim, 2016, CWP232228 targets liver cancer stem cells through Wnt/beta-catenin signaling: a novel therapeutic approach for liver cancer treatment, Oncotarget, 7, 20395, 10.18632/oncotarget.7954
Jonker, 2018, Napabucasin versus placebo in refractory advanced colorectal cancer: a randomised phase 3 trial, Lancet Gastroenterol. Hepatol., 3, 263, 10.1016/S2468-1253(18)30009-8
Emami, 2004, A small molecule inhibitor of beta-catenin/CREB-binding protein transcription [corrected], Proc. Natl. Acad. Sci. U.S.A., 101, 12682, 10.1073/pnas.0404875101
Urushibara, 2017, WNT/beta-catenin signaling inhibitor IC-2 suppresses sphere formation and sensitizes colorectal Cancer cells to 5-Fluorouracil, Anticancer Res., 37, 4085
Gurney, 2012, Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors, Proc. Natl. Acad. Sci. U. S. A., 109, 11717, 10.1073/pnas.1120068109
Palmer, 2001, Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling, J. Cell Biol., 154, 369, 10.1083/jcb.200102028
Ng, 2008, Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer, J. Clin. Oncol., 26, 2984, 10.1200/JCO.2007.15.1027
Ng, 2009, Prospective study of predictors of vitamin D status and survival in patients with colorectal cancer, Br. J. Cancer, 101, 916, 10.1038/sj.bjc.6605262
Ng, 2011, Vitamin D status in patients with stage IV colorectal cancer: findings from Intergroup trial N9741, J. Clin. Oncol., 29, 1599, 10.1200/JCO.2010.31.7255
Hsieh, 2011, Hepatitis B viral X protein interacts with tumor suppressor adenomatous polyposis coli to activate Wnt/beta-catenin signaling, Cancer Lett., 300, 162, 10.1016/j.canlet.2010.09.018
Jaiswal, 2002, Beta-catenin-mediated transactivation and cell-cell adhesion pathways are important in curcumin (diferuylmethane)-induced growth arrest and apoptosis in colon cancer cells, Oncogene, 21, 8414, 10.1038/sj.onc.1205947
Su, 2009, Soy isoflavone genistein upregulates epithelial adhesion molecule E-cadherin expression and attenuates beta-catenin signaling in mammary epithelial cells, Carcinogenesis, 30, 331, 10.1093/carcin/bgn279
Hwang, 2005, Combination of 5-fluorouracil and genistein induces apoptosis synergistically in chemo-resistant cancer cells through the modulation of AMPK and COX-2 signaling pathways, Biochem. Biophys. Res. Commun., 332, 433, 10.1016/j.bbrc.2005.04.143
Zhang, 2011, Fluorinated N,N-dialkylaminostilbenes for Wnt pathway inhibition and colon cancer repression, J. Med. Chem., 54, 1288, 10.1021/jm101248v
Howells, 2011, Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases--safety, pharmacokinetics, and pharmacodynamics, Cancer Prev. Res. Phila. (Phila), 4, 1419, 10.1158/1940-6207.CAPR-11-0148
Leem, 2015, Genome-wide transcriptome analysis reveals inactivation of Wnt/beta-catenin by 3,3’-diindolylmethane inhibiting proliferation of colon cancer cells, Int. J. Oncol., 47, 918, 10.3892/ijo.2015.3089
Kang, 2012, Wnt/beta-catenin signaling mediates the antitumor activity of magnolol in colorectal cancer cells, Mol. Pharmacol., 82, 168, 10.1124/mol.112.078535
Kundu, 2017, 1-Benzyl-indole-3-carbinol is a highly potent new small molecule inhibitor of Wnt/beta-catenin signaling in melanoma cells that coordinately inhibits cell proliferation and disrupts expression of microphthalmia-associated transcription factor isoform-M, Carcinogenesis, 38, 1207, 10.1093/carcin/bgx103
Park, 2018, Lycopene treatment inhibits activation of Jak1/Stat3 and Wnt/beta-catenin signaling and attenuates hyperproliferation in gastric epithelial cells, Nutr. Res.
Feitelson, 2015, Sustained proliferation in cancer: mechanisms and novel therapeutic targets, Semin. Cancer Biol., 35, S25, 10.1016/j.semcancer.2015.02.006
Arber, 2006, Celecoxib for the prevention of colorectal adenomatous polyps, N. Engl. J. Med., 355, 885, 10.1056/NEJMoa061652
He, 1999, PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs, Cell, 99, 335, 10.1016/S0092-8674(00)81664-5
Cuzick, 2015, Estimates of benefits and harms of prophylactic use of aspirin in the general population, Ann. Oncol., 26, 47, 10.1093/annonc/mdu225
Bartscherer, 2008, Regulation of Wnt protein secretion and its role in gradient formation, EMBO Rep., 9, 977, 10.1038/embor.2008.167
Liu, 2013, Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974, Proc. Natl. Acad. Sci. U. S. A., 110, 20224, 10.1073/pnas.1314239110
Lu, 2014, Salinomycin suppresses LRP6 expression and inhibits both Wnt/beta-catenin and mTORC1 signaling in breast and prostate cancer cells, J. Cell. Biochem., 115, 1799, 10.1002/jcb.24850
Metcalfe, 2010, Dvl2 promotes intestinal length and neoplasia in the ApcMin mouse model for colorectal cancer, Cancer Res., 70, 6629, 10.1158/0008-5472.CAN-10-1616
Guo, 2009, Mutations in the human naked cuticle homolog NKD1 found in colorectal cancer alter Wnt/Dvl/beta-catenin signaling, PLoS One, 4, e7982, 10.1371/journal.pone.0007982
Warren, 1994, The oncogenic cysteine-rich LIM domain protein rbtn2 is essential for erythroid development, Cell, 78, 45, 10.1016/0092-8674(94)90571-1
Kishida, 1998, Axin, a negative regulator of the wnt signaling pathway, directly interacts with adenomatous polyposis coli and regulates the stabilization of beta-catenin, J. Biol. Chem., 273, 10823, 10.1074/jbc.273.18.10823
Jin, 2003, Detection of point mutations of the Axin1 gene in colorectal cancers, Int. J. Cancer, 107, 696, 10.1002/ijc.11435
Chen, 2010, Development of small molecules targeting the Wnt pathway for the treatment of colon cancer: a high-throughput screening approach, Am. J. Physiol. Gastrointest. Liver Physiol., 299, G293, 10.1152/ajpgi.00005.2010
Lu, 2009, Structure-activity relationship studies of small-molecule inhibitors of Wnt response, Bioorg. Med. Chem. Lett., 19, 3825, 10.1016/j.bmcl.2009.04.040
Huang, 2009, Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling, Nature, 461, 614, 10.1038/nature08356
Coghlan, 2000, Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription, Chem. Biol., 7, 793, 10.1016/S1074-5521(00)00025-9
Massarsky, 2018, Total particulate matter from cigarette smoke disrupts vascular development in zebrafish brain (Danio rerio), Toxicol. Appl. Pharmacol., 339, 85, 10.1016/j.taap.2017.12.003
Sato, 2004, Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor, Nat. Med., 10, 55, 10.1038/nm979
Atkinson, 2015, Activating the Wnt/beta-Catenin pathway for the treatment of melanoma--Application of LY2090314, a novel selective inhibitor of glycogen synthase Kinase-3, PLoS One, 10, 10.1371/journal.pone.0125028
Chen, 2009, 2,4-Diamino-quinazolines as inhibitors of beta-catenin/Tcf-4 pathway: Potential treatment for colorectal cancer, Bioorg. Med. Chem. Lett., 19, 4980, 10.1016/j.bmcl.2009.07.070
Li, 2015, Suppression of cancer relapse and metastasis by inhibiting cancer stemness, Proc. Natl. Acad. Sci. U. S. A., 112, 1839, 10.1073/pnas.1424171112
Locken, 2018, Napabucasin and related Heterocycle-Fused Naphthoquinones as STAT3 inhibitors with antiproliferative activity against Cancer cells, J. Nat. Prod., 81, 1636, 10.1021/acs.jnatprod.8b00247
Bromberg, 2000, The role of STATs in transcriptional control and their impact on cellular function, Oncogene, 19, 2468, 10.1038/sj.onc.1203476
Hubbard, 2017, Napabucasin: an update on the first-in-Class Cancer stemness inhibitor, Drugs, 77, 1091, 10.1007/s40265-017-0759-4
Bendell, 2017, LBA-003Phase 1b/II study of cancer stemness inhibitor napabucasin in combination with FOLFIRI +/- bevacizumab (bev) in metastatic colorectal cancer (mCRC) patients (pts), Ann. Oncol., 28
Sampietro, 2006, Crystal structure of a beta-catenin/BCL9/Tcf4 complex, Mol. Cell, 24, 293, 10.1016/j.molcel.2006.09.001
Kawamoto, 2009, Analysis of the interaction of BCL9 with beta-catenin and development of fluorescence polarization and surface plasmon resonance binding assays for this interaction, Biochemistry, 48, 9534, 10.1021/bi900770z
Ma, 2005, Differential roles for the coactivators CBP and p300 on TCF/beta-catenin-mediated survivin gene expression, Oncogene, 24, 3619, 10.1038/sj.onc.1208433
Eguchi, 2005, ICG-001, a novel small molecule regulator of TCF/beta-catenin transcription, Med. Chem., 1, 467, 10.2174/1573406054864098
McMillan, 2005, Investigating Wnt signaling: a chemogenomic safari, Drug Discov. Today, 10, 1467, 10.1016/S1359-6446(05)03613-5
Niehrs, 2012, The complex world of WNT receptor signalling, Nat. Rev. Mol. Cell Biol., 13, 767, 10.1038/nrm3470
Maelandsmo, 2003, Reduced beta-catenin expression in the cytoplasm of advanced-stage superficial spreading malignant melanoma, Clin. Cancer Res., 9, 3383
Bachmann, 2005, Importance of P-cadherin, beta-catenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma, Clin. Cancer Res., 11, 8606, 10.1158/1078-0432.CCR-05-0011
Huber, 2001, The structure of the beta-catenin/E-cadherin complex and the molecular basis of diverse ligand recognition by beta-catenin, Cell, 105, 391, 10.1016/S0092-8674(01)00330-0